WebJul 8, 2024 · Sir, The recent article of “FAST-Forward” in breast cancer has aroused significant interest.[] Brunt et al. report that, for early-stage breast cancer, a dose of 26 … WebDec 10, 2024 · Wendy Woodward, MD, PhD. In April 2024, at the height of the first wave of the COVID-19 pandemic, the 5-year efficacy results of the FAST-Forward trial were published showing that 1 week of whole breast radiotherapy was noninferior to the standard schedule given over 3 weeks for women with early-stage breast cancer after primary …
The Lancet The best science for better lives
WebJul 8, 2024 · Sir, The recent article of “FAST-Forward” in breast cancer has aroused significant interest.[] Brunt et al. report that, for early-stage breast cancer, a dose of 26 Gy in five fractions over 1 week for breast radiotherapy is noninferior to the existing standard of 40 Gy in 15 fractions over 3 weeks for local tumor control and is safe in terms of normal … WebFAST-Forward_protocol v5.1 5 Feb 2024 clean.docx 1 FAST-Forward Randomised clinical trial testing a 1-week course of curative whole breast radiotherapy against a standard 3 … mfrs 16 discount rate
FAST-Forward Trial in Breast Cancer: A Prospective Pilot Study ...
WebAim: of this study is to determine the temporal resolution of therapy-induced pneumonitis, and to assess promoting factors in adjuvant treated patients with unilateral mammacarcinoma. Patients and methods: A total of 100 post-surgery patients were recruited. The cohort was treated by 2 field radiotherapy (2FRT; breast and chest wall, N … WebJan 20, 2024 · The non-inferiority and safety of 26Gy/5 fractions in comparison to the standard 40Gy/15 fractions of adjuvant RT in early-stage breast cancer has been … WebApr 1, 2024 · Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial mfrs 9 download